The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
Market view
safinamide mesylate · Powder
6 marketed package NDCs · 6 active manufacturers
Most dispensed: 100 mg · Tablet, Film Coated · #1 bottle/carton / 30 tablet, film coated in 1 bottle · 50 mg · Tablet, Film Coated · #1 bottle/carton / 30 tablet, film coated in 1 bottle · 1 kg/kg · Powder · #50 kg/drum
What changed in the last 90 days
Every detected change for safinamide mesylate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Same drug class
Other molecules FDA puts in Monoamine Oxidase Type B Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Safinamide mesylate in shortage right now?
- No. FDA does not currently list Safinamide mesylate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Safinamide mesylate?
- 7 companies have marketed Safinamide mesylate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Safinamide mesylate cost?
- The typical pharmacy pays about $36.39 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.